The Research Group for Peptide-Based Drug Discovery (Prof. Nathalie M. Grob) at ETH Zurich, in collaboration with Novo Nordisk in Copenhagen, Denmark, is seeking an exceptional and highly motivated PhD candidate for a joint project. This full-time (100%) PhD position is aimed at individuals with a strong interest in peptide chemistry, mass spectrometry, and modern drug discovery to establish an innovative platform for peptide drug discovery.
Peptides are privileged modalities in the development of new therapeutic avenues. To address unexploited targets and provide alternative therapeutic strategies for established disease pathways, the discovery of bioactive peptides is a fundamental challenge. This project emphasizes the development of novel technologies for hit identification and validation with the goal of achieving high experimental throughput and success rates.
The four-year project is co-funded by Novo Nordisk and will be supervised by Prof. Nathalie Grob (ETH Zurich) in cooperation with Novo Nordisk. This role presents a unique opportunity to work at the intersection of academia and industry, utilizing cutting-edge technology to make a meaningful impact in peptide drug discovery. Short research visits (up to 3 months) at the Novo Nordisk research site in Copenhagen and access to high-throughput instrumentation are planned throughout the project. Candidates with prior experience in peptide synthesis, mammalian tissue culture, and mass spectrometry will find a significant advantage.
To contribute effectively to this project, candidates should be prepared to integrate into a multidisciplinary team, balancing independent work with collaborative discussions. Responsibilities will include:
The ideal candidate will possess a recently completed MSc degree or equivalent in Chemistry, Pharmacy, Pharmaceutical Sciences, Chemical Biology, Cellular Biology, or related fields. Candidates should also have experience in several of the following areas:
A successful applicant will demonstrate a passion for science and collaboration, accompanied by strong motivation and a deep interest in drug discovery and development. Proficiency in English is required to thrive in a multidisciplinary environment.
Applicants should be ready to start the project by October 1, 2025, and must have authorization to work in Switzerland and to travel to Denmark for short-term projects (under 3 months) without requiring additional permits.
[Details about the workplace can be inserted here]
ETH Zurich fosters an inclusive culture that promotes equality of opportunity, values diversity, and nurtures a working and learning environment that respects the rights and dignity of all staff and students. Visit our Equal Opportunities and Diversity website to learn how we cultivate a fair and open environment that supports growth and success.
Apply online using the form below. Only applications matching the job profile will be considered.
For questions regarding the position, please reach out to Prof. Nathalie M. Grob at Tel [+41 44 633 74 57] or via email at [nathalie.grob@pharma.ethz.ch].
ETH Zurich is one of the world’s leading universities specializing in science and technology. We are renowned for our excellent education, cutting-edge fundamental research, and the direct transfer of new knowledge into society. With over 30,000 individuals from more than 120 countries, our university promotes independent thinking and creates an inspiring environment for excellence. Located in the heart of Europe yet connected globally, we collaborate to devise solutions for today’s and tomorrow’s challenges.
Location : Zürich
Country : Switzerland